Insiders Rigel Pharmaceuticals, Inc.

Equities

RIGL

US7665596034

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
1.05 ^USD	-1.87%		-7.89%	-27.59%

Apr. 12	Rigel Pharmaceuticals, Inc. Enters into Amendment No. 4 to that Certain Credit and Security Agreement	CI
Mar. 12	Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer as Chief Medical Officer	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer as Chief Medical Officer	Mar. 12	CI
Athersys Names Jane Wasman as Board Chair	23-10-02	MT
Rigel Pharmaceuticals, Inc. Announces Second -2-2-Appointment of Olutasidenib as Therapeutics	23-06-06	CI
Rigel Pharmaceuticals, Inc. Announces Resignation of Wolfgang Dummer as Executive Vice President and Chief Medical Officer, Effective March 31, 2023	23-02-03	CI
Insider Buy: Rigel Pharmaceuticals	22-06-13	MT
Rigel Pharmaceuticals, Inc. Appoints Kamil Ali-Jackson to Board of Directors	21-12-16	CI
Rigel Pharmaceuticals, Inc. Appoints Alison L. Hannah, M.D. to Its Board of Directors	21-05-14	CI
Rigel Pharmaceuticals, Inc. Announces Resignation of Nelson D. Cabatuan as Vice President, Finance and Principal Accounting Officer, Effective on October 16, 2020	20-10-08	CI
Rigel Pharmaceuticals, Inc. Appoints Dave Santos as Executive Vice President and Chief Commercial Officer	20-08-04	CI
Eldon C. Mayer Informes Rigel Pharmaceuticals, Inc. to Resign as the Company’s Chief Commercial Officer, Effective as of December 23, 2019	19-12-17	CI
Rigel Pharmaceuticals, Inc. Names Wolfgang Dummer as Chief Medical Officer	19-10-23	CI
Rigel Pharmaceuticals, Inc. Announces Resignation of Anne-Marie Duliege, Executive Vice President and Chief Medical Officer, Effective August 31, 2019	19-05-16	CI
Peter S. Ringrose Announces Not to Stand for Re-Election to Board of Rigel Pharmaceuticals, Inc	19-04-09	CI
Rigel Pharmaceuticals, Inc. Announces Board Changes	19-03-26	CI
Rigel Pharmaceuticals, Inc. Appoints Dean Schorno as Executive Vice President and Chief Financial Officer	18-05-30	CI
Rigel Pharmaceuticals Announces Executive Changes	17-12-15	CI
Rigel Pharmaceuticals, Inc. Appoints Gregg A. Lapointe to the Board of Directors and Audit Committee	17-11-03	CI
Rigel Pharmaceuticals, Inc. Appoints Brian L. Kotzin to Its Board of Directors	17-08-25	CI
Rigel Pharmaceuticals, Inc. Announces New Hires	17-08-01	CI
Rigel Pharmaceuticals Receives Approval from Food and Drug Administration for Tavalisse as Proprietary Name for Fostamatinib in the United States	17-04-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Rigel Pharmaceuticals, Inc.

Equities

RIGL

US7665596034

Insiders

Filters